The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(2-((6-oxo-4-propyl-1,6-dihydropyrimidin-2-yl)thio)acetyl)-4,5-dihydro-1H-benzo[b]azepin-2(3H)-one ID: ALA5203670
Chembl Id: CHEMBL5203670
PubChem CID: 135858320
Max Phase: Preclinical
Molecular Formula: C19H21N3O3S
Molecular Weight: 371.46
Associated Items:
Names and Identifiers Canonical SMILES: CCCc1cc(=O)[nH]c(SCC(=O)c2ccc3c(c2)CCCC(=O)N3)n1
Standard InChI: InChI=1S/C19H21N3O3S/c1-2-4-14-10-18(25)22-19(20-14)26-11-16(23)13-7-8-15-12(9-13)5-3-6-17(24)21-15/h7-10H,2-6,11H2,1H3,(H,21,24)(H,20,22,25)
Standard InChI Key: WVRKQDZPZOUPNW-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 371.46Molecular Weight (Monoisotopic): 371.1304AlogP: 2.97#Rotatable Bonds: 6Polar Surface Area: 91.92Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.70CX Basic pKa: 0.33CX LogP: 2.94CX LogD: 2.79Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.46Np Likeness Score: -1.59
References 1. He S, Liu Y, Chu X, Li Q, Lyu W, Liu Y, Xing S, Feng F, Liu W, Guo Q, Zhao L, Sun H.. (2022) Discovery of Novel Aldo-Keto Reductase 1C3 Inhibitors as Chemotherapeutic Potentiators for Cancer Drug Resistance., 13 (8.0): [PMID:35978698 ] [10.1021/acsmedchemlett.2c00175 ]